Kinase Focused Library

Kinase is an enzyme that adds phosphate groups to substrate molecules, and this process is known as phosphorylation. Protein phosphorylation plays an important role in regulating a large number of cellular processes such as cell division, metabolism, and signal transduction, and 50% of cellular functions in the human genome are regulated by kinases. Kinases therefore are essential in new drug development, and protein kinases are one of the most promising drug targets in anticancer drug development. Many protein kinases are encoded in the human genome, and kinase inhibitors are an important class of drugs that block the activity of certain disease-related enzymes, such as cancer and inflammation. Although there are many reported kinase modulators, most of them share similar structural and selective issues.

BOC Sciences provides its unique protein kinase focused library, which contains approximately 32,000 drug-like screening compounds selected by ligand-based methods.

Processes leading to dissociation of the intramolecular inhibitory interaction in PKC and to activation of the enzyme.  Figure 1. Processes leading to dissociation of the intramolecular inhibitory interaction in PKC and to activation of the enzyme. (Mochly-Rosen, D.; et al. 2012)

Library Design

  1. Firstly, a reference set containing more than 135,000 compounds with reported kinase inhibitory activity (IC50, Ki et al.; <10 μM, inhibition>50%) is extracted from a database with reliable sources
  2. Then, we perform a a 2D fingerprint similarity search against the reference set of protein kinase activity modulators to analyze the the BOC Sciences HTS compound collection
  3. Finally, the resulting screened compounds will be further filtered through an internal filter to remove PAINS, toxic substances and reactive fractions

Our well-designed kinase focused library contains analogs of kinase inhibitors against the following molecular targets:

  • 3-phosphoinositide dependent protein kinase-1
  • MAP kinase signal-integrating kinase 2
  • 6-phospho-1-fructokinase
  • MAP kinase-activated protein kinase 2
  • 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
  • MAP kinase-interacting ser/threonine-protein kinase MNK1
  • Adenosine kinase
  • MAP/microtubule affinity-regulating kinase 2
  • Autoinducer 1 sensor kinase/phosphatase luxN
  • Maternal embryonic leucine zipper kinase
  • Bcr/Abl fusion protein
  • Mitogen-activated protein kinase (4, 5, 7, 8, 14)
  • CAI-1 autoinducer sensor kinase/phosphatase CqsS
  • Myosin light chain kinase, smooth muscle
  • Calcium-dependent protein kinase (1, 4)
  • Nerve growth factor receptor Trk-A
  • CaM kinase (I alpha, II delta, IV, alpha, beta)
  • Pantothenate kinase 3
  • cAMP-dependent protein kinase alpha
  • PAS domain-containing ser/threonine-protein kinase
  • Casein kinase (I alpha, delta, epsilon, gamma, II)
  • Phosphatidylinositol 4,5-bisphosphate 3-kinase Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma
  • CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase)
  • Phosphatidylinositol-5-phosphate 4-kinase type-2 (alpha, gamma)
  • CDK-interacting protein 1
  • Phosphoglycerate kinase
  • Cdk-related protein kinase 6
  • PI3-kinase p110 (alpha, beta, delta, gamma subunits)
  • Cell division cycle 7-related protein kinase
  • PI4-kinase (alpha, beta subunits)
  • Cell division protein kinase 8
  • Platelet-derived growth factor receptor (alpha, beta)
  • c-Jun N-terminal kinase (1, 2, 3)
  • Protein arginine N-methyltransferase 5
  • Connector enhancer of kinase suppressor of ras 1
  • Protein kinase 6
  • Cyclin-dependent kinase (1, 1/cyclin B, 1/cyclin B1, 2, 2/cyclin A, 2/cyclin E, 2/cyclin E1, 4, 4/cyclin D, 4/cyclin D1, 5, 5/CDK5 activator 1, 6, 7, 7/ cyclin H, 9)
  • Protein kinase C (alpha, eta, iota, mu, theta, zeta)
  • Death-associated protein kinase (1, 3)
  • Protein kinase Pfmrk
  • Discoidin domain-containing receptor 2
  • Protein tyrosine kinase 2 beta
  • DNA-dependent protein kinase
  • Proto-oncogene tyrosine-protein kinase MER
  • Dual specificity mitogen-activated protein kinase (1, 2)
  • Putative hexokinase HKDC1
  • Dual specificity protein kinase (CLK1, CLK4, TTK)
  • Putative uncharacterized protein pk7
  • Dual specificity tyrosine-phosphorylation-regulated kinase (1A, 1B, 2)
  • Pyridoxal kinase
  • Enteropeptidase
  • Pyruvate dehydrogenase kinase (1, 2, 3)
  • Ephrin type-A receptor (2, 4)
  • Pyruvate kinase
  • Ephrin type-B receptor (3, 4)
  • Pyruvate kinase isozymes M1/M2
  • Epidermal growth factor receptor ErbB1 and ErbB2 Epithelial discoidin domain-containing receptor 1
  • RAC-alpha serine/threonine-protein kinase
  • Eukaryotic translation initiation factor 2-alpha kinase 3
  • Receptor protein-tyrosine kinase erbB-2
  • Fibroblast growth factor receptor (1, 2, 3)
  • Receptor-interacting ser/threonine-protein kinase 1
  • Focal adhesion kinase 1
  • Rho-associated protein kinase (1, 2)
  • G protein-coupled receptor kinase 6
  • Ribosomal protein S6 kinase (1, alpha 2, alpha 3, alpha 5)
  • Glycogen synthase kinase (3 alpha, beta)
  • Serine/threonine-protein kinase (17B, 33, AKT, AKT2, Aurora-A, Aurora-B, B-raf, Chk1, Chk2, c-TAK1, EEF2K, ILK-1, MRCK-A, mTOR, PAK 1, PAK 4, PIM1, PIM2, PIM3, pknB, PLK1, PLK2, PLK3, PLK4, RAF, R3, Sgk1, ATM, TAO1, TAO2, TAO3)
  • G-protein coupled receptor kinase 2
  • Serine/threonine-protein kinase/endoribonuclease IRE1
  • Hepatocyte growth factor receptor
  • Sphingosine kinase (1, 2)
  • Hexokinase type IV
  • Streptokinase A
  • Histidine kinase
  • Testis-specific serine/threonine-protein kinase 1
  • Homeodomain-interacting protein kinase 2
  • TGF-beta receptor type (I, II)
  • Inhibitor of nuclear factor kappa B kinase (beta, epsilon)
  • TRAF2- and NCK-interacting kinase
  • Insulin-like growth factor I receptor
  • Transient receptor potential cation channel subfamily M member 7
  • Interleukin-1 receptor-associated kinase 4
  • Tyrosine kinase non-receptor protein 2
  • KinA/Spo0F (sporulation kinase A/sporulation initiation phosphotransferase F)
  • Tyrosine-protein kinase (ABL, ALK, BRK, BTK, FES, FYN, ITK/TSK, JAK1, JAK2, JAK3, LCK, Lyn, FLT3, RET,
  • Leucine-rich repeat ser/threonine-protein kinase 2
  • UFO, SRC, SYK, TIE-2, TYK2, YES)
  • LIM domain kinase (1, 2)
  • Uridine-cytidine kinase 2
  • Macrophage-stimulating factor receptor kinase
  • Urokinase-type plasminogen activator
  • MAP kinase (ERK1, ERK2, p38-alpha, beta, delta)
  • Vascular endothelial growth factor receptor (1, 2)

Domain composition of PKC family members. Figure 2. Domain composition of PKC family members. (Mochly-Rosen, D.; et al. 2012)

Kinase Focused Library Characteristics

  • No PAINS or toxic substances/unwanted functions: filtered by strict ‘Ro5-like’ physicochemical and most stringent in-house structural filters
  • Confirmed bioactivity and safety by preclinical studies and clinical trials
  • Targets involved PI3K, HDAC, mTOR, CDK, JAK and other cancer-related targets
  • Structural diversity, significant efficacy, and cellular penetration
  • Structural document, IC50, and other chemical and biological data are provided
  • Tanimoto index ≥ 0.85
  • All compounds are continually updated
  • Compound cherry-picking service is provided

What We Deliver

  • Delivered within 2 weeks in any customer-preferred format
  • Powders, dry films or DMSO solutions formatted in vials, 96 or 384-well plates
  • All compounds have a minimum purity of 90% assessed by 1H NMR and HPLC
  • Analytical data is provided

BOC Sciences provides professional, rapid and high-quality services of Kinase Focused Library design at competitive prices for global customers. Personalized and customized services of Kinase Focused Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!

Reference

  1. Mochly-Rosen, D.; et al. an elusive therapeutic target?. Nature Reviews Drug Discovery. 2012.
Our mission is to provide clients with a professional chemical library design platform. Empowered by high-quality services and effective research solutions, we are committed to helping customers achieve effective and successful research goals.

Online Inquiry

Verification code
Services Based on the Chemical Library Design Platform

Services Based on the Chemical Library Design Platform

BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.

BACK TO TOP